Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Taiwan study site entry was updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305. The postal code remains the same, but the city designation is clarified to Taoyuan.
    Difference
    0.0%
    Check dated 2026-05-05T12:48:11.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.5.3 has been added, replacing Revision: v3.5.2. This indicates a minor site update that does not affect page content or functionality.
    Difference
    0.0%
    Check dated 2026-04-28T07:51:25.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site’s interface revision was updated from v3.5.0 to v3.5.2 without changing the clinical study details shown on the page.
    Difference
    0.0%
    Check dated 2026-04-21T01:22:23.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now includes updated definitions and timeframes for primary/secondary outcomes (PFS, OS, ORR), added PK data details, and an additional Naples, Italy site.
    Difference
    1.0%
    Check dated 2026-03-23T06:31:50.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-09T00:26:56.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page shows a minor version update from Revision: v3.4.1 to Revision: v3.4.2; no study data or visible content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:02:22.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.